{
    "nctId": "NCT02617043",
    "briefTitle": "Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery",
    "officialTitle": "Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Numbers of participants with treatment-related toxicity assessed by CTCAE v4.0",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* 18-60 years old\n* Treated with breast conversing surgery and sentinel lymph node biopsy or axillary lymph node dissection\n* Pathologically confirmed invasive breast cancer\n* A pathological T1-2N0M0 tumor\n* Tumor bed is labeled with Titanium clips\n* Negative surgical margins\n* Written informed consent.\n\nExclusion Criteria:\n\n* KPS\\<70\n* Treated with neoadjuvant chemotherapy\n* Sentinel lymph nodes only containing isolated tumour cells (\\<0.2 mm)\n* With severe comorbidity\n* Previous breast cancer or other malignant tumor history\n* Previous radiotherapy for breast or thorax\n* Medical contraindication for radiotherapy\n* Pregnant or nursing",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}